%0 Journal Article
%T 甲状腺滤泡癌的诊断和治疗热点<br>Hotspots of diagnosis and treatment of follicular thyroid carcinoma
%A 殷德涛
%A 唐艺峰
%J 西安交通大学学报(医学版)
%D 2019
%R 10.7652/jdyxb201903001
%X 摘要：甲状腺滤泡癌是滤泡细胞衍生的一种甲状腺癌，属于分化型甲状腺癌，其发病率仅次于甲状腺乳头状癌，是甲状腺癌第二常见的组织学类型。甲状腺滤泡癌占所有甲状腺癌的10%～15%。其死亡率高于甲状腺乳头状癌，部分患者初治时已经发现骨或肺的转移。早期诊治和密切随访是改善预后、延长术后生存期的主要手段。甲状腺滤泡癌常以临床病理血管、包膜浸润为诊断依据，有时因未见明确的浸润灶或取材不足而漏诊，超声及细针穿刺诊断困难，而细胞学标记物检测目前并不成熟。本文总结目前甲状腺滤泡癌的诊断及治疗的热点，旨在提高我们对甲状腺滤泡癌的认识。<br>ABSTRACT: Follicular thyroid carcinoma (FTC), a thyroid cancer derived from follicular cells, belongs to the differentiated thyroid carcinoma. It is the second most common histological type of thyroid carcinoma after papillary thyroid carcinoma (PTC). FTC accounts for 10% to 15% of all thyroid carcinomas. It has a higher mortality rate than PTC. Bone or lung metastases have been found in some patients at initial treatment. Early diagnosis and close follow-up are the main methods to improve its prognosis and prolong postoperative survival. FTC is often diagnosed based on clinical pathological vascular and capsule infiltration. Sometimes missed diagnosis occurs because there is no clear infiltration or insufficient material. However, cytological markers are not mature currently. This article summarizes the hotspots of diagnosis and treatment of FTC to improve our understanding of FTC
%K 甲状腺滤泡癌
%K 分化型甲状腺癌
%K 诊断和治疗<br>follicular thyroid carcinoma
%K differentiated thyroid carcinoma
%K diagnosis and treatment
%U http://yxxb.xjtu.edu.cn//oa/darticle.aspx?type=view&id=201903001